中資券商股快速拉昇 外媒稱中信證券和中信建投考慮合併
格隆匯4月14日丨受中信證券和中信建投考慮合併的傳聞影響,A股市場中信證券和中信建投直線拉昇,中信建投一度直線拉昇漲停,中信證券也一度拉漲超6%。同時帶動整個券商板塊走強。港股市場中資券商股跟隨上漲,目前,中信建投漲超9%領漲,中信證券漲超4%,海通證券、東方證券、中國銀河和光大證券均漲超2%。據彭博,知情人士稱,中信證券、中信建投以及兩家公司主要股東中信集團和中央匯金等,正就兩家證券公司合併的可能性進行研究。知情人士稱,相關討論已經彙報給中國證監會以及國資委,但該事項仍處於初步階段,尚未形成最終計劃,也並不肯定會達成合並。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.